Exogenous cannabinoids have been reported to mediate antitumor activity via Akt/PI3K inhibition13,17,18,34,57–61 and JNK activation18,27,61–63 through CB1R and/or CB2R in various cancer cells including NSCLC. This evidence concerns the gene MAPK8 and non-small cell lung carcinoma.